Clinical Trials Browser

Lymphoma, B-Cell × Cell- and Tissue-Based Therapy × Clear all

NCT05322330 2023-02-09

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell

NCT05312476 2022-04-05

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell